Doxorubicin Hydrochloride

Doxorubicin Hydrochloride__Autophagy inducer GSK2330672

Product Name Doxorubicin Hydrochloride
Description

Autophagy inducer

Purity >98% (TLC); NMR (Conforms)
CAS No. 25316-40-9
Molecular Formula C27H29NO11•HCl
Molecular Weight 580
Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Inducer
Solubility Soluble in water (50 mM).
Source Synthetic
Appearance Red solid
SMILES email protected2(OC1OC(C(O)C(N)C1)C)CC@@(O)(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)C(=O)CO.H+.Cl-
InChI InChI=1S/C27H29NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3
InChIKey MWWSFMDVAYGXBV-RUELKSSGSA-N
Safety Phrases Classification: Not WHMIS controlled.
Safety Phrases:
S22 – Do not breathe dust.
S24/25 – Avoid contact with skin and eyes.
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection.
Hazard statements:
H302- Harmful if swallowed.
H350- May cause cancer.
Precautionary statements:
P201- Obtain special instructions before use.
P308 + P313- IF exposed or concerned: Get medical advice/ attention.
Cite This Product Doxorubicin Hydrochloride (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-390)

References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/19121623

Alternative Names Adriamycin
Research Areas Cancer, Autophagy
PubChem ID 443939
Scientific Background Doxorubicin Hydrochloride is used in a clinical setting for the treatment of a wide range of cancers, including lymphomas, leukemias, and solid tumors of the breast, pancreas, stomach, bladder, and ovaries. This drug intercalates into DNA and therefore induces apoptosis by hindering cellular functions like replication and transcription by specifically inhibiting the binding of reverse transcriptase, RNA polymerase and topoisomerase II. Doxorubicin has some adverse effects for patients including immunosuppressive effects caused by hematologic toxicity. Doxorubicin has also been shown to induce autophagy in a species-specific manner.
References 1. Kusayanagi, T. et al. (2012). Bioorg Med Chem. 20(21): 6248-55.
2. Chen, N. T. et al. (2012). PLoS One. 7(9).
3. Patel, S. et al. (1997). Mol Pharmacol. 52(4): 658-66.
4. Cutts, S. et al. (1996). J Biol Chem. 271(10): 5422-9.
5. Danesi, R. et al. (2004). Transplant Proc. 36(3): 703-4.
6. Dirks-Naylor, A. (2013). Life Sci. 93(24): 913-6.